Main characteristics of hepatocellular carcinoma and cirrhosis and therapeutic approaches

S Elba1, G P Buongiorno, M L Caruso

  • 1Div. di Gastroenterologia, Serv. di Anatomia Patologica, I.R.C.C.S. S. De Bellis , Castellana Grotte, Italy.

Insights

This study on hepatocarcinoma (HCC) and cirrhosis patients found that most cases were mononodular and right-lobed. Histological differentiation varied, with no clear link between nodule number and differentiation grade.

Area of Science:

  • Hepatology
  • Oncology
  • Gastroenterology

Background:

  • Hepatocellular carcinoma (HCC) is a major complication of cirrhosis.
  • Understanding HCC characteristics is crucial for patient management and treatment strategies.

Purpose of the Study:

  • To characterize the clinical and pathological features of HCC in patients with cirrhosis.
  • To investigate correlations between imaging findings, histology, and nodule characteristics.

Main Methods:

  • Prospective study of 100 patients with HCC and cirrhosis between 1995-1997.
  • Data collection included patient demographics, etiology (Hepatitis B, Hepatitis C, alcohol), alpha-foetoprotein levels, portal thrombosis, tumor characteristics (nodularity, lobe), echographic patterns, and histological differentiation (Edmonson grade).

Main Results:

  • The study included 74 males and 26 females with a mean age of 66 years.
  • Hepatitis C virus (HCV) was the most common etiology (75%), followed by Hepatitis B virus (HBV) (13%).
  • Mononodular HCC was prevalent (63%), predominantly in the right lobe (79%), with hypoechoic patterns on echography (70%).
  • Histologically, 49% were well-differentiated, 45% moderately-differentiated, and 6% poorly-differentiated.
  • No significant correlation was found between histological pattern and the number of nodules or the Edmonson grade.

Conclusions:

  • Mononodular HCC, often right-lobed and hypoechoic on ultrasound, is common in cirrhotic patients.
  • While histological differentiation varies, it does not strongly correlate with nodule number or specific etiologies in this cohort.
  • Further research is needed to explore prognostic factors in HCC.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...